View Financial HealthRobertet 배당 및 자사주 매입배당 기준 점검 4/6Robertet 수익으로 충분히 충당되는 현재 수익률 1.47% 보유한 배당금 지급 회사입니다. 다음 지급일은 1st July, 2026 이며 배당락일은 다음과 같습니다. 29th June, 2026.핵심 정보1.5%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률1.8%배당 성장률10.2%다음 배당 지급일01 Jul 26배당락일29 Jun 26주당 배당금n/a배당 성향25%최근 배당 및 자사주 매입 업데이트Declared Dividend • May 04Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (38% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.Upcoming Dividend • Jun 20Upcoming dividend of €10.00 per shareEligible shareholders must have bought the stock before 27 June 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).Declared Dividend • Apr 28Dividend increased to €10.00Dividend of €10.00 is 18% higher than last year. Ex-date: 27th June 2025 Payment date: 1st July 2025 Dividend yield will be 1.2%, which is lower than the industry average of 3.0%.Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.8%).모든 업데이트 보기Recent updatesDeclared Dividend • May 04Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (38% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Apr 28Robertet SA, Annual General Meeting, Jun 03, 2026Robertet SA, Annual General Meeting, Jun 03, 2026. Location: 48 avenue jean maubert, grasse FranceReported Earnings • Apr 17Full year 2025 earnings releasedFull year 2025 results: Revenue: €849.8m (up 5.2% from FY 2024). Net income: €103.4m (up 15% from FY 2024). Profit margin: 12% (up from 11% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.공시 • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.공시 • Feb 12Robertet SA to Report First Half, 2026 Final Results on Sep 21, 2026Robertet SA announced that they will report first half, 2026 final results on Sep 21, 2026Board Change • Jan 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Lucie Maurel-Aubert was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jan 02+ 2 more updatesRobertet SA to Report Fiscal Year 2025 Results on Apr 09, 2026Robertet SA announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 09, 2026공시 • Sep 12Robertet SA to Report First Half, 2025 Final Results on Sep 18, 2025Robertet SA announced that they will report first half, 2025 final results on Sep 18, 2025공시 • Jul 25Robertet SA to Report First Half, 2025 Results on Sep 11, 2025Robertet SA announced that they will report first half, 2025 results on Sep 11, 2025Upcoming Dividend • Jun 20Upcoming dividend of €10.00 per shareEligible shareholders must have bought the stock before 27 June 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).공시 • Apr 29Robertet SA, Annual General Meeting, Jun 04, 2025Robertet SA, Annual General Meeting, Jun 04, 2025. Location: 48 avenue jean maubert, grasse FranceDeclared Dividend • Apr 28Dividend increased to €10.00Dividend of €10.00 is 18% higher than last year. Ex-date: 27th June 2025 Payment date: 1st July 2025 Dividend yield will be 1.2%, which is lower than the industry average of 3.0%.공시 • Nov 06Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation.Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation on November 4, 2024.Reported Earnings • Sep 27First half 2024 earnings released: EPS: €24.71 (vs €19.14 in 1H 2023)First half 2024 results: EPS: €24.71 (up from €19.14 in 1H 2023). Revenue: €414.6m (up 10% from 1H 2023). Net income: €51.7m (up 29% from 1H 2023). Profit margin: 13% (up from 11% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Board Change • Jun 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Lucie Maurel-Aubert was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 22Full year 2023 earnings released: EPS: €35.71 (vs €32.85 in FY 2022)Full year 2023 results: EPS: €35.71. Revenue: €735.6m (up 4.6% from FY 2022). Net income: €74.6m (down 1.9% from FY 2022). Profit margin: 10% (in line with FY 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 2.4% decline forecast for the Chemicals industry in the United Kingdom.New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.공시 • Apr 12+ 2 more updatesRobertet SA to Report First Half, 2024 Results on Sep 23, 2024Robertet SA announced that they will report first half, 2024 results on Sep 23, 2024Buy Or Sell Opportunity • Apr 09Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €807. The fair value is estimated to be €1,011, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Buy Or Sell Opportunity • Feb 21Now 22% undervaluedOver the last 90 days, the stock has risen 4.5% to €794. The fair value is estimated to be €1,024, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Buy Or Sell Opportunity • Feb 21Now 22% undervaluedOver the last 90 days, the stock has risen 4.8% to €794. The fair value is estimated to be €1,022, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Reported Earnings • Oct 05First half 2023 earnings released: EPS: €19.13 (vs €19.49 in 1H 2022)First half 2023 results: EPS: €19.13 (down from €19.49 in 1H 2022). Revenue: €376.4m (up 4.9% from 1H 2022). Net income: €39.9m (down 11% from 1H 2022). Profit margin: 11% (down from 13% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.8%).Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Director Elie Vannier was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • May 01Full year 2021 earnings releasedFull year 2021 results: Revenue: €608.8m (up 13% from FY 2020). Net income: €71.7m (up 42% from FY 2020). Profit margin: 12% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11% compared to a 16% decline forecast for the industry in the United Kingdom.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 01First half 2021 earnings released: EPS €16.47 (vs €13.03 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €297.6m (up 6.2% from 1H 2020). Net income: €38.1m (up 27% from 1H 2020). Profit margin: 13% (up from 11% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 05Full year 2020 earnings released: EPS €21.88 (vs €22.96 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €538.3m (down 2.9% from FY 2019). Net income: €50.6m (down 4.7% from FY 2019). Profit margin: 9.4% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Is New 90 Day High Low • Jan 29New 90-day high: €955The company is up 3.0% from its price of €923 on 30 October 2020. The British market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.Is New 90 Day High Low • Dec 11New 90-day low: €546The company is down 45% from its price of €996 on 11 September 2020. The British market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €546, the stock is trading at a trailing P/E ratio of 36.9x, down from the previous P/E ratio of 59.8x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 40%.Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 36.9x, down from the previous P/E ratio of 60.7x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Valuation Update With 7 Day Price Move • Dec 07Market pulls back on stock over the past weekAfter last week's 40% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.3x, down from the previous P/E ratio of 63.4x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Valuation Update With 7 Day Price Move • Dec 03Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 63.2x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 63.8x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Valuation Update With 7 Day Price Move • Nov 27Market pulls back on stock over the past weekAfter last week's 40% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 64.1x. This compares to an average P/E of 37x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Valuation Update With 7 Day Price Move • Nov 24Market pulls back on stock over the past weekAfter last week's 42% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.5x, down from the previous P/E ratio of 66.8x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Is New 90 Day High Low • Nov 20New 90-day low: €546The company is down 39% from its price of €897 on 21 August 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.Valuation Update With 7 Day Price Move • Nov 20Market pulls back on stock over the past weekAfter last week's 42% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.5x, down from the previous P/E ratio of 66.8x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.Is New 90 Day High Low • Oct 12New 90-day high: €1,036The company is up 8.0% from its price of €958 on 13 July 2020. The British market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.Reported Earnings • Oct 02First half earnings releasedOver the last 12 months the company has reported total profits of €53.7m, largely unchanged from the prior year. Total revenue was €547.4m over the last 12 months, up 1.0% from the prior year.예정된 배당 지급오늘May 26 2026배당락일Jun 29 2026배당 지급일Jul 01 20262 days (배당락일 기준)다음 배당금을 받으려면 앞으로 34 days일 이내에 매수하세요지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 0NZN 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: 0NZN 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Robertet 배당 수익률 vs 시장0NZN의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (0NZN)1.5%시장 하위 25% (GB)2.2%시장 상위 25% (GB)5.6%업계 평균 (Chemicals)3.7%분석가 예측 (0NZN) (최대 3년)1.8%주목할만한 배당금: 0NZN 의 배당금( 1.47% )은 UK 시장에서 배당금 지급자의 하위 25%( 2.23% )와 비교해 주목할 만하지 않습니다.고배당: 0NZN 의 배당금( 1.47% )은 UK 시장에서 배당금 지급자의 상위 25%( 5.64% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 25.4% )로 0NZN 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 39.9% )로 0NZN 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YGB 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 22:44종가2026/05/25 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Robertet SA는 15명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Fraser DonlonBerenbergMarie-Line FortBernsteinNicola TangBNP Paribas12명의 분석가 더 보기
Declared Dividend • May 04Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (38% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.
Upcoming Dividend • Jun 20Upcoming dividend of €10.00 per shareEligible shareholders must have bought the stock before 27 June 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).
Declared Dividend • Apr 28Dividend increased to €10.00Dividend of €10.00 is 18% higher than last year. Ex-date: 27th June 2025 Payment date: 1st July 2025 Dividend yield will be 1.2%, which is lower than the industry average of 3.0%.
Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.8%).
Declared Dividend • May 04Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (38% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Apr 28Robertet SA, Annual General Meeting, Jun 03, 2026Robertet SA, Annual General Meeting, Jun 03, 2026. Location: 48 avenue jean maubert, grasse France
Reported Earnings • Apr 17Full year 2025 earnings releasedFull year 2025 results: Revenue: €849.8m (up 5.2% from FY 2024). Net income: €103.4m (up 15% from FY 2024). Profit margin: 12% (up from 11% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.
공시 • Feb 12Robertet SA to Report First Half, 2026 Final Results on Sep 21, 2026Robertet SA announced that they will report first half, 2026 final results on Sep 21, 2026
Board Change • Jan 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Lucie Maurel-Aubert was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jan 02+ 2 more updatesRobertet SA to Report Fiscal Year 2025 Results on Apr 09, 2026Robertet SA announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 09, 2026
공시 • Sep 12Robertet SA to Report First Half, 2025 Final Results on Sep 18, 2025Robertet SA announced that they will report first half, 2025 final results on Sep 18, 2025
공시 • Jul 25Robertet SA to Report First Half, 2025 Results on Sep 11, 2025Robertet SA announced that they will report first half, 2025 results on Sep 11, 2025
Upcoming Dividend • Jun 20Upcoming dividend of €10.00 per shareEligible shareholders must have bought the stock before 27 June 2025. Payment date: 01 July 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).
공시 • Apr 29Robertet SA, Annual General Meeting, Jun 04, 2025Robertet SA, Annual General Meeting, Jun 04, 2025. Location: 48 avenue jean maubert, grasse France
Declared Dividend • Apr 28Dividend increased to €10.00Dividend of €10.00 is 18% higher than last year. Ex-date: 27th June 2025 Payment date: 1st July 2025 Dividend yield will be 1.2%, which is lower than the industry average of 3.0%.
공시 • Nov 06Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation.Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation on November 4, 2024.
Reported Earnings • Sep 27First half 2024 earnings released: EPS: €24.71 (vs €19.14 in 1H 2023)First half 2024 results: EPS: €24.71 (up from €19.14 in 1H 2023). Revenue: €414.6m (up 10% from 1H 2023). Net income: €51.7m (up 29% from 1H 2023). Profit margin: 13% (up from 11% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Board Change • Jun 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Lucie Maurel-Aubert was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 22Full year 2023 earnings released: EPS: €35.71 (vs €32.85 in FY 2022)Full year 2023 results: EPS: €35.71. Revenue: €735.6m (up 4.6% from FY 2022). Net income: €74.6m (down 1.9% from FY 2022). Profit margin: 10% (in line with FY 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 2.4% decline forecast for the Chemicals industry in the United Kingdom.
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.
공시 • Apr 12+ 2 more updatesRobertet SA to Report First Half, 2024 Results on Sep 23, 2024Robertet SA announced that they will report first half, 2024 results on Sep 23, 2024
Buy Or Sell Opportunity • Apr 09Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €807. The fair value is estimated to be €1,011, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Buy Or Sell Opportunity • Feb 21Now 22% undervaluedOver the last 90 days, the stock has risen 4.5% to €794. The fair value is estimated to be €1,024, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Buy Or Sell Opportunity • Feb 21Now 22% undervaluedOver the last 90 days, the stock has risen 4.8% to €794. The fair value is estimated to be €1,022, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 5.1% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Reported Earnings • Oct 05First half 2023 earnings released: EPS: €19.13 (vs €19.49 in 1H 2022)First half 2023 results: EPS: €19.13 (down from €19.49 in 1H 2022). Revenue: €376.4m (up 4.9% from 1H 2022). Net income: €39.9m (down 11% from 1H 2022). Profit margin: 11% (down from 13% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.8%).
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Director Elie Vannier was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • May 01Full year 2021 earnings releasedFull year 2021 results: Revenue: €608.8m (up 13% from FY 2020). Net income: €71.7m (up 42% from FY 2020). Profit margin: 12% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11% compared to a 16% decline forecast for the industry in the United Kingdom.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 01First half 2021 earnings released: EPS €16.47 (vs €13.03 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €297.6m (up 6.2% from 1H 2020). Net income: €38.1m (up 27% from 1H 2020). Profit margin: 13% (up from 11% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 05Full year 2020 earnings released: EPS €21.88 (vs €22.96 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €538.3m (down 2.9% from FY 2019). Net income: €50.6m (down 4.7% from FY 2019). Profit margin: 9.4% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Is New 90 Day High Low • Jan 29New 90-day high: €955The company is up 3.0% from its price of €923 on 30 October 2020. The British market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
Is New 90 Day High Low • Dec 11New 90-day low: €546The company is down 45% from its price of €996 on 11 September 2020. The British market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €546, the stock is trading at a trailing P/E ratio of 36.9x, down from the previous P/E ratio of 59.8x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 40%.
Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 36.9x, down from the previous P/E ratio of 60.7x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Valuation Update With 7 Day Price Move • Dec 07Market pulls back on stock over the past weekAfter last week's 40% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.3x, down from the previous P/E ratio of 63.4x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Valuation Update With 7 Day Price Move • Dec 03Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 63.2x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 39% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 63.8x. This compares to an average P/E of 38x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Valuation Update With 7 Day Price Move • Nov 27Market pulls back on stock over the past weekAfter last week's 40% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.7x, down from the previous P/E ratio of 64.1x. This compares to an average P/E of 37x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Valuation Update With 7 Day Price Move • Nov 24Market pulls back on stock over the past weekAfter last week's 42% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.5x, down from the previous P/E ratio of 66.8x. This compares to an average P/E of 40x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Is New 90 Day High Low • Nov 20New 90-day low: €546The company is down 39% from its price of €897 on 21 August 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 20Market pulls back on stock over the past weekAfter last week's 42% share price decline to €546, the stock is trading at a trailing P/E ratio of 38.5x, down from the previous P/E ratio of 66.8x. This compares to an average P/E of 39x in the Chemicals industry in the United Kingdom. Total returns to shareholders over the past three years are 39%.
Is New 90 Day High Low • Oct 12New 90-day high: €1,036The company is up 8.0% from its price of €958 on 13 July 2020. The British market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.
Reported Earnings • Oct 02First half earnings releasedOver the last 12 months the company has reported total profits of €53.7m, largely unchanged from the prior year. Total revenue was €547.4m over the last 12 months, up 1.0% from the prior year.